MAPK7 and prostate cancer: Expression of nuclear ERK5 is upregulated in prostate cancers showing high-grade Gleason and bone metastasis (McCracken et al., 2008; Clape et al., 2009; Ramsay et al., 2011; Ahmad et al., 2013).